Day: September 24, 2024

Allschwil, Switzerland, September 24, 2024 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today that it has initiated the Fosmanogepix Against Standard-of-care Treatment in Invasive Candidiasis (FAST-IC) phase 3 study. This registrational study evaluates the efficacy and safety of Basilea’s broad-spectrum antifungal fosmanogepix in the treatment of adult patients with candidemia and/or invasive candidiasis, that is Candida yeast bloodstream or deep-seated tissue infections.1  Fosmanogepix is a first-in-class antifungal treatment candidate with a novel mechanism of action. It is available in intravenous and oral formulations and has been evaluated for efficacy and safety in a phase 1 / phase 2...

Ad hoc-Mitteilung gemäss Art. 53 des Kotierungsreglements der SIX Schweiter Technologies Innovation & Capital Markets Day 2024 Profitable growth with sharpened strategySharpened strategic focusLightweight composite solutions in 4 attractive markets (Display, Core Materials, Architecture, Transport & Industry) delivering against megatrends Market segment specific growth initiatives defined focusing on innovations and leveraging leading position Profitability improvement driven by “Accelerate” program, economies of scale and operational excellence measuresOver the cycle ambitionOrganic growth above market growth EBIT margin growing to a range of 7% to 9% Improving Return on Invested Capital to a range of 9% to 11%Steinhausen, September 24, 2024 – Schweiter Technologies is today holding its Innovation & Capital...

Free virtual event features Grammy-winning artist and cultural icon Jon BatistePractice speaking a new language with Lily! With Duolingo’s new Video Call feature, you can chat with the purple-haired queen of sarcasm whenever you want. No pressure, no fake smiles—just real conversations. And maybe some silent judgment. Video Call is available now on Duolingo Max.Dr. Luis von Ahn is the CEO and co-founder of Duolingo. A MacArthur Fellow and co-inventor of CAPTCHAs, Luis has been named one of the 10 Most Brilliant Scientists by Popular Science Magazine and one of the 100 Most Innovative People in Business by Fast Company Magazine. – – – Presented as part of Duolingo Duocon 2024, a free global event at the intersection of language, learning, and technology: https://www.duolingo.com/duocon...

Caufield, Australia, Sept. 23, 2024 (GLOBE NEWSWIRE) — Nova Minerals Limited (“Nova” and the “Company”) (Nasdaq NVA, NVAWW) (ASX: NVA), (OTC: NVAAF)(FSE: QM3)), a gold and critical minerals exploration stage company focused on advancing the Estelle Gold Project in Alaska, U.S.A., today announced the pricing of an underwritten public offering of 430,000 American Depository Shares (“ADS”), with an ADS-to-ordinary-share ratio of 1 to 60, at a price to the public of $5.00 per ADS, for gross proceeds of $2,150,000, before deducting underwriting discounts and offering expenses. In addition, Nova has granted the underwriters a 45-day option to purchase up to an additional 43,000 ADSs to cover over-allotments, if any. The Company intends to use the proceeds for resource and exploration field programs, including additional drilling...

Toronto, Sept. 23, 2024 (GLOBE NEWSWIRE) — Faircourt Asset Management Inc., as Manager of the Faircourt Fund (NEO:FGX), is pleased to announce the monthly distribution payable on the Shares of the below listed Fund.Faircourt Funds Trading Symbol Distribution Amount (per share/unit) Ex-Dividend Date Record Date Payable DateFaircourt Gold Income Corp. FGX $0.024 September 27, 2024 September 30, 2024 October 15, 2024Faircourt Asset Management Inc. is the Investment Advisor for Faircourt Gold Income Corp. This press release is not for distribution in the United States or over United States wire services. For further information on the Faircourt Funds, please visit www.faircourtassetmgt.com or please contact 1-800-831-0304. You will usually pay brokerage fees to your dealer if you purchase or sell Shares of the Fund on the...